期刊
JOURNAL OF CONTEMPORARY BRACHYTHERAPY
卷 12, 期 3, 页码 294-302出版社
TERMEDIA PUBLISHING HOUSE LTD
DOI: 10.5114/jcb.2020.96874
关键词
nasopharyngeal carcinoma; interstitial brachytherapy boost; image-guided brachytherapy
资金
- Japan Agency for Medical Research and Development (AMED) [19ck0106305h0003]
- National Cancer Center Research and Development Fund [26-A-18, 26-A-28]
- Project of Social Development Division in Department of Science and Technology of Jilin Province [20190303151SF]
Nasopharyngeal cancer generally responds well to concurrent chemoradiotherapy (CCRT). However, there is a small group of patients who respond poorly to CCRT, and experience local residual tumor or local relapse. Although several attempts have been performed to such a group of patients including re-irradiation with external beam radiation therapy (EBRT) or salvage surgery, clinical results remain unsatisfactory. Intracavitary brachytherapy (ICBT) boost after CCRT with EBRT has been explored, however, its efficacy is limited to those with superficial residual tumors. For those residual tumors thickness with more than 5 mm, interstitial brachytherapy (ISBT) boost would be an appropriate modality of choice. Here, we describe technical aspects of the high-dose-rate interstitial brachytherapy (HDR-ISBT) boost for nasopharyngeal cancer (NPC) patients who responded poorly to the CCRT with EBRT.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据